Evaluation of Medication Adherence and Quality of Life in Patients with Benign Prostatic Hyperplasia

Swetha Narayan; Divya Jyothi S; MI Rahman; Chetak Raghavan; Shivakumar Babu

doi:10.36948/ijfmr.2025.v07i06.60982

Evaluation of Medication Adherence and Quality of Life in Patients with Benign Prostatic Hyperplasia

Author(s)	Dr. Swetha Narayan, Dr. Divya Jyothi S, Dr. MI Rahman, Dr. Chetak Raghavan, Dr. Shivakumar Babu
Country	India
Abstract	Benign Prostatic Hyperplasia (BPH) is a non-malignant enlargement of the prostate gland that surrounds the urethra, leading to lower urinary tract symptoms (LUTS) such as nocturia, urgency, frequency, and incomplete bladder emptying. These symptoms result from urethral compression and bladder outlet obstruction, which, if left untreated, can lead to complications including acute urinary retention, bladder stones, urinary tract infections, and renal impairment. This study aimed to evaluate the relationship between medication adherence and quality of life among patients diagnosed with BPH. An observational study was conducted among 101 outpatients from the Department of Urology, ESI PGIMSR and Model Hospital, Rajajinagar, Bengaluru. Data were collected using validated questionnaires: the SF-36 for assessing quality of life and the Medication Adherence Rating Scale (MARS) for evaluating adherence levels. Demographic data were analyzed using descriptive statistics, and the association between medication adherence and quality of life was examined using Spearman’s rho correlation analysis in SPSS version 24. The majority of patients were within the age group of 60–69 years. The correlation analysis revealed a statistically significant positive relationship (P = 0.040) between medication adherence and quality of life, suggesting that patients with higher adherence to their prescribed therapy experienced better quality of life outcomes. The study concludes that improving medication adherence plays a crucial role in enhancing the overall well-being and clinical outcomes of patients with BPH, emphasizing the importance of patient education and continuous follow-up to optimize treatment benefits.
Keywords	Benign Prostatic Hyperplasia, Quality of life, Medication adherence, Silodosin, Dutasteride.
Field	Medical / Pharmacy
Published In	Volume 7, Issue 6, November-December 2025
Published On	2025-11-18
DOI	https://doi.org/10.36948/ijfmr.2025.v07i06.60982

View / Download PDF File

E-ISSN 2582-2160

doi

CrossRef DOI is assigned to each research paper published in our journal.

IJFMR DOI prefix is
10.36948/ijfmr

Downloads

Research Paper Format Copyright Permission Form and Undertaking Form Cover Page Vol 8 Isu 3 Cover Page Vol 8 Isu 2 Cover Page Vol 8 Isu 2

All research papers published on this website are licensed under Creative Commons Attribution-ShareAlike 4.0 International License, and all rights belong to their respective authors/researchers.

CC-BY-SA

About IJFMR Fees & Payment Current Issue Publication Archive	Submit Research Paper Track Submission Status Publication Guidelines Publication Ethics Peer Review & Plagiarism	Join as a Reviewer Editors & Reviewers Reviewer Referral Program Get Reviewer Membership Certi.	Website/Journal Policies Usage Policy Content Policies Privacy Policy

Contact Us		+91-9687-828-838	editor@ijfmr.com

International Journal For Multidisciplinary Research

A Widely Indexed Open Access Peer Reviewed Multidisciplinary Bi-monthly Scholarly International Journal

Evaluation of Medication Adherence and Quality of Life in Patients with Benign Prostatic Hyperplasia

Share this